This is the authors' abstract. We don't add key points for this paper.
British Journal of HaematologyEarly View LETTER TO THE EDITOR Lymphoplasmacytic lymphoma presenting cold agglutinin syndrome: Clonal expansion of KMT2D and IGHV4-34 mutations after COVID-19 Kiyohito Hayashi, Kiyohito Hayashi Department of Hematology, Fukushima Medical University, Fukushima, JapanSearch for more papers by this authorDaisuke Koyama, Corresponding Author Daisuke Koyama [email protected] orcid.org/0000-0002-6971-180X Department of Hematology, Fukushima Medical University, Fukushima, Japan Correspondence Daisuke Koyama, Department of Hematology, Fukushima Medical University, Fukushima 960-1295, Japan. Email: [email protected]Search for more papers by this authorYuki Sato, Yuki Sato Department of Hematology, Fukushima Medical University, Fukushima, JapanSearch for more papers by this authorMasahiko Fukatsu, Masahiko Fukatsu Department of Hematology, Fukushima Medical University, Fukushima, JapanSearch for more papers by this authorTakayuki Ikezoe, Takayuki Ikezoe Department of Hematology, Fukushima Medical University, Fukushima, JapanSearch for more papers by this author Kiyohito Hayashi, Kiyohito Hayashi Department of Hematology, Fukushima Medical University, Fukushima, JapanSearch for more papers by this authorDaisuke Koyama, Corresponding Author Daisuke Koyama [email protected] orcid.org/0000-0002-6971-180X Department of Hematology, Fukushima Medical University, Fukushima, Japan Correspondence Daisuke Koyama, Department of Hematology, Fukushima Medical University, Fukushima 960-1295, Japan. Email: [email protected]Search for more papers by this authorYuki Sato, Yuki Sato Department of Hematology, Fukushima Medical University, Fukushima, JapanSearch for more papers by this authorMasahiko Fukatsu, Masahiko Fukatsu Department of Hematology, Fukushima Medical University, Fukushima, JapanSearch for more papers by this authorTakayuki Ikezoe, Takayuki Ikezoe Department of Hematology, Fukushima Medical University, Fukushima, JapanSearch for more papers by this author First published: 11 September 2023 https://doi.org/10.1111/bjh.19106Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms. Leukemia. 2022; 36: 1720–1748. 2Malecka A, Troen G, Tierens A, Ostlie I, Malecki J, Randen U, et al. Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity. Haematologica. 2016; 101: e361–e364. 3Misawa K, Yasuda H, Koyama D, Inano T, Inoguchi A, Shirasu C, et al. Adult paroxysmal cold hemoglobinuria following mRNA COVID-19 vaccination. EJHaem. 2022; 3: 992–995. 4Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022; 140: 1229–1253. 5Hunter ZR, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. Blood. 2014; 123: 1637–1646. 6Malecka A, Delabie J, Ostlie I, Tierens A, Randen U, Berentsen S, et al. Cold agglutinin-associated B-cell lymphoproliferative disease shows highly recurrent gains of chromosome 3 and 12 or 18. Blood Adv. 2020; 4: 993–996. 7Randen U, Troen G, Tierens A, Steen C, Warsame A, Beiske K, et al. Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma. Haematologica. 2014; 99: 497–504. 8Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. N Engl J Med. 2012; 367: 826–833. 9Potter KN, Hobby P, Klijn S, Stevenson FK, Sutton BJ. Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen. J Immunol. 2002; 169: 3777–3782. 10Chang CY, Chin HH, Chin PW, Zaid M. Cold agglutinin-mediated autoimmune haemolytic anaemia associated with COVID-19 infection: a case report. Hong Kong Med J. 2022; 28: 257–259. 11Dawudi Y, Federici L, Debus J, Zucman N. Cold agglutinin disease secondary to severe SARS-CoV-2 treated with eculizumab. BMJ Case Rep. 2022; 15:e242937. 12Imoto H, Yoshioka S, Nakagawa D, Hasegawa K, Kuroda H, Hasuike T, et al. Cold agglutinin anti-I antibodies in two patients with COVID-19. J Clin Lab Anal. 2022; 36:e24629. 13Treon SP. How I treat Waldenström macroglobulinemia. Blood. 2015; 126: 721–732. 14Pratt G, El-Sharkawi D, Kothari J, D'Sa S, Auer R, McCarthy H, et al. Diagnosis and management of Waldenstrom macroglobulinaemia–A British Society for Haematology guideline. Br J Haematol. 2022; 197: 171–187. 15Jacobs JW, Booth GS. COVID-19 and immune-mediated RBC destruction. Am J Clin Pathol. 2022; 157: 844–851. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hayashi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: